Yüklüyor......
Analysis of MLN4924 (Pevonedistat) as a Potential Therapeutic Agent in Malignant Melanoma
The NEDD8 pathway is a known activator of the ubiquitin-protease system, a complex partially responsible for the degradation of proteins involved in cell-cycle regulation and neoplastic growth. In this study, we evaluated the anti-tumor potential of MLN4924 (pevonedistat); a potent NEDD8 inhibitor....
Kaydedildi:
| Yayımlandı: | Melanoma Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6110958/ https://ncbi.nlm.nih.gov/pubmed/30020196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000474 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|